A new policy shift is reshaping the landscape for GLP-1 drugs, signaling major financial effects for Medicare, insurers, and ...

The prescription drug legislation in the Inflation Reduction Act of 2022 — backed by AARP — directed the Department of Health and Human Services to work with pharmaceutical companies to secure reduced ...

The grant has a balance of $184,596.57. Street Manager Brian Green mailed 250 letters to city residents who have potential planting sites. Residents were given the option to opt out within a certain ...

A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs. The Trump ...

New York is now running its own, far more modest pilot in state-level comfort. Democratic Governor Kathy Hochul has announced ...

Ironwood Pharmaceuticals soared by 23.32 percent on Wednesday to end at $3.86 apiece as investors cheered the new price set ...

The government said Tuesday that Novo Nordisk's (NVO) drugs - Ozempic and Rybelsus for Type 2 diabetes - will cost $274 for a month's supply in 2027 for people covered by Medicare. Wegovy, which is ...

E2 says renewable and EV project cancellations have topped $28.7 billion in 2025, with nearly 30,000 jobs lost as new ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

In 2026, there are fewer prescription drug plans in Medicare Part D and higher premiums, even when offset by a ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

On Tuesday, the Trump administration celebrated drug price cuts it had secured through a Democrat-created program — despite Republicans’ longstanding antipathy of the policy.